Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
J Cereb Blood Flow Metab. 2013 Feb;33(2):287-92. doi: 10.1038/jcbfm.2012.168. Epub 2012 Nov 14.
Coated-platelets are procoagulant platelets observed upon dual-agonist stimulation with collagen and thrombin. Coated-platelet levels are elevated in patients with nonlacunar (large-vessel) ischemic stroke and decreased in patients with spontaneous intracerebral hemorrhage as compared with controls. The purpose of this study was to investigate a possible relationship between coated-platelet levels and stroke recurrence in patients with nonlacunar ischemic stroke. We assayed coated-platelet levels in 190 consecutive patients with nonlacunar stroke who were followed for up to 12 months; 20 subjects experienced recurrent stroke. Subjects were categorized into tertiles of coated-platelet levels. The distributions of time-to-recurrent stroke were estimated for each tertile using cumulative incidence curves and compared statistically using a log-rank test. The cumulative incidence of recurrent stroke at 12 months differed among the coated-platelet tertiles: 2% for the first tertile (lowest coated-platelet levels), 18% for the second tertile, and 17% for the third tertile (overall log-rank test, P=0.019). These data suggest that higher levels of coated-platelets, measured shortly after a nonlacunar stroke, are associated with an increased incidence of stroke recurrence. This observation offers an additional tool for identifying patients at highest risk for stroke recurrence following a nonlacunar (large-vessel) infarct.
被覆血小板是在胶原和凝血酶双重激动下观察到的促凝血小板。与对照组相比,非腔隙性(大血管)缺血性脑卒中患者的被覆血小板水平升高,自发性脑出血患者的被覆血小板水平降低。本研究旨在探讨非腔隙性缺血性脑卒中患者被覆血小板水平与脑卒中复发之间的可能关系。我们检测了 190 例连续的非腔隙性脑卒中患者的被覆血小板水平,这些患者的随访时间长达 12 个月;其中 20 例患者发生了复发性脑卒中。将患者按被覆血小板水平分为三分位。使用累积发病率曲线估计每个三分位数的复发性脑卒中时间,并使用对数秩检验进行统计学比较。被覆血小板三分位组的复发性脑卒中累积发生率不同:第 1 三分位(最低被覆血小板水平)为 2%,第 2 三分位为 18%,第 3 三分位为 17%(总体对数秩检验,P=0.019)。这些数据表明,非腔隙性脑卒中后短时间内测量的较高水平的被覆血小板与脑卒中复发的发生率增加有关。这一观察结果为识别非腔隙性(大血管)梗死患者中脑卒中复发风险最高的患者提供了另一种工具。